Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA. Shares in the company gained almost 24% ...

Scott Paisant shared his story on the air Friday and with WWL's Meg Farris. He hopes that his story will help others to recognize signs of a medical issue early.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.